• Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?

  • May 2 2024
  • Duración: 13 m
  • Podcast
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum? Por arte de portada

Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • A.M. Edition for May 2. Danish pharmaceutical giant Novo Nordisk upped its full-year guidance today as it reported continued strong demand for its blockbuster weight-loss and diabetes drugs. Barclays analyst Emily Field discusses where the drugmaker could go from here. Plus, Exxon Mobil reaches an agreement to close its $60 billion merger with Pioneer. And TikTok strikes a licensing deal to return Universal Music artists to the platform. Luke Vargas hosts. Listening on Google Podcasts? Here's our guide for switching to a different podcast player. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
Política y Gobierno
Más Menos

Lo que los oyentes dicen sobre Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles